Rarely acquired type II-A CRISPR-Cas spacers mediate anti-viral immunity through the targeting of a non-canonical PAM sequence is a research paper published in Nucleic Acids Research (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: T32GM07739
NIH NRSA F31 Individual Predoctoral Fellowship to Promote Diversity
Grant: F31GM134665
NIH Director's Pioneer Award
Grant: DP1GM128184
National Institutes of Health
Grant: 5F31GM134665-02
Elucidating Mechanisms of Adaptive Immunity in Type II-A CRISPR-Cas
National Institutes of Health
Grant: 5DP1GM128184-02
Generation of immunological memory by CRISPR-Cas systems
National Institutes of Health
Grant: 5T32GM007739-30
Weill Cornell/Rockefeller/Sloan-Kettering MST Program
Howard Hughes Medical Institute
FWCI
0.81
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals